Last updated on: 10/27/2011 | Author:

Should cannabidiol (CBD) be a medical option?

NEW: Should cannabidiol (CBD) be a medical option? – Cannabidiol (CBD) is the main non-psychoactive chemical component of marijuana. The US Department of Health and Human Services (HHS) was awarded a patent for CBD on Oct. 7, 2003. However, the US Drug Enforcement Agency (DEA) classifies CBD as a Schedule I drug, meaning it is considered to have “no accepted medical use,” “a high potential for abuse,” and “a lack of accepted safety for use of the drug or other substance under medical supervision.” Given the large volume of studies on CBD, the HHS patent of this Schedule I drug, and the growing attention CBD receives, we have compiled the best pro and con arguments from major players in the CBD debate to help our readers better understand this controversy.